within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03A_DrugsForFunctionalGastrointestinalDisorders.A03AA04_Mebeverine;

model Mebeverine
  extends Pharmacolibrary.Drugs.ATC.A.A03AA04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A03AA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mebeverine is a musculotropic antispasmodic agent used to relieve symptoms of irritable bowel syndrome (IBS) such as abdominal pain and cramps, bowel disturbances, and intestinal discomfort. It acts primarily as a smooth muscle relaxant and is not associated with anticholinergic side effects. Mebeverine is still approved and used in several countries for IBS management.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported after oral administration of a single mebeverine 135 mg tablet in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Stockis, A, et al., &amp; de Vos, D (2002). Identification of mebeverine acid as the main circulating metabolite of mebeverine in man. <i>Journal of pharmaceutical and biomedical analysis</i> 29(1-2) 335–340. DOI:<a href=\"https://doi.org/10.1016/s0731-7085(02)00023-7\">10.1016/s0731-7085(02)00023-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12062694/\">https://pubmed.ncbi.nlm.nih.gov/12062694</a></p></li><li><p>Dickinson, RG, et al., &amp; Hooper, WD (1991). Facile hydrolysis of mebeverine in vitro and in vivo: negligible circulating concentrations of the drug after oral administration. <i>Journal of pharmaceutical sciences</i> 80(10) 952–957. DOI:<a href=\"https://doi.org/10.1002/jps.2600801010\">10.1002/jps.2600801010</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1784004/\">https://pubmed.ncbi.nlm.nih.gov/1784004</a></p></li><li><p>Sommers, DK, et al., &amp; Eloff, JN (1997). Lack of bioavailability of mebeverine even after pretreatment with pyridostigmine. <i>European journal of clinical pharmacology</i> 53(3-4) 247–249. DOI:<a href=\"https://doi.org/10.1007/s002280050370\">10.1007/s002280050370</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9476039/\">https://pubmed.ncbi.nlm.nih.gov/9476039</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Mebeverine;
